Senior insider sale
SVP, Research at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$4.40M
55.17K shares
What this filing means
SWAYZE ERIC plans to sell 55.17K shares of IONIS PHARMACEUTICALS INC valued at approximately $4.40M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/13/2026ACC: 0001972481-26-000055
Officer· SVP, Research
Since Jan 2020
55.17K
Shares to sell
$4.40M
Approx. market value
15.64K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
1/15/2026
15.64KTotal acquired15.64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2026 | Restricted Stock Units Equity Compensation | 15.64K | — |
| Total | 15.64K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
6.18K
Market value
$512.9K
1/30/2026
—Completed
Units to sell
9.88K
Market value
$753.5K
1/16/2026
—Completed
Units to sell
23.46K
Market value
$1.85M
1/2/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
15.64K
Market value
$1.28M
2/13/2026
Total
Units
55.17K
Value
$4.40M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/30/2026 | 6.18K | $512.9K | — | Completed |
1/16/2026 | 9.88K | $753.5K | — | Completed |
1/2/2026 | 23.46K | $1.85M | — | Completed |
| Planned — Approximate Date | ||||
2/13/2026 | 15.64K | $1.28M | Nasdaq | Planned |
| Total | 55.17K | $4.40M | ||